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Abstract
Background  and  objectives:  Sevoﬂurane  is  often  used  in  pediatric  anesthesia  and  is  associated
with high  incidence  of  psychomotor  agitation.  In  such  cases,  dexmedetomidine  (DEX)  has  been
used, but  its  beneﬁt  and  implications  remain  uncertain.  We  assessed  the  effects  of  DEX  on
agitation in  children  undergoing  general  anesthesia  with  sevoﬂurane.
Method:  Meta-analysis  of  randomized  clinical  and  double-blind  studies,  with  children  under-
going elective  procedures  under  general  anesthesia  with  sevoﬂurane,  using  DEX  or  placebo.
We sought  articles  in  English  in  PubMed  database  using  the  following  terms:  Dexmedetomidine,
sevoﬂurane  (Methyl  Ethers/sevoﬂurante),  and  agitation  (Psychomotor  Agitation).  Duplicate  arti-
cles with  children  who  received  premedication  and  used  active  control  were  excluded.  It  was
adopted  random  effects  model  with  DerSimonian--Laird  testing  and  odds  ratio  (OR)  calculation
for dichotomous  variables,  and  standardized  mean  difference  for  continuous  variables,  with
their respective  95%  conﬁdence  interval  (CI).
Results:  Of  146  studies  identiﬁed,  10  were  selected  totaling  558  patients  (282  in  DEX  group
and 276  controls).  The  use  of  DEX  was  considered  a  protective  factor  for  psychomotor  agitation3;  p  <  0.0001)  and  nausea  and  vomiting  in  PACU  (OR  =  0.49;  95%  CI
e-up  time  and  PACU  discharge  time  were  higher  in  the  dexmedeto-
o  difference  between  groups  for  extubation  time  and  duration  of(OR =  0.17;  95%  CI  0.13--0.2
0.35--0.68;  p  <  0.0001).  Wak
midine group.  There  was  nPlease  cite  this  article  in  press  as:  Amorim  MA,  et  al.  Effect  of  dexmedetomidine  in  children  undergoing  general  anesthesia
with  sevoﬂurane:  a  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2016.02.007
anesthesia.
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Conclusion:  Dexmedetomidine  reduces  psychomotor  agitation  during  wake-up  time  of  children
undergoing  general  anesthesia  with  sevoﬂurane.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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sevoﬂurano:  uma  metanálise
Resumo
Justiﬁcativa  e  objetivos:  Sevoﬂurano  é  frequentemente  usado  em  anestesia  pediátrica  e  está
associado  à  alta  incidência  de  agitac¸ão  psicomotora  ao  despertar.  Nesses  casos  a  dexmedeto-
midina (dex)  tem  sido  usada,  porém  permanecem  incertos  seus  benefícios  e  suas  implicac¸ões.
Foram avaliados  os  efeitos  da  dex  sobre  a  agitac¸ão  no  despertar  de  crianc¸as  submetidas  à
anestesia  geral  com  sevoﬂurano.
Método:  Metanálise  de  ensaios  clínicos  randomizados  e  duplamente  encobertos,  com  crianc¸as
submetidas  a  procedimentos  eletivos  sob  anestesia  geral  com  sevoﬂurano,  que  usaram  dex
ou placebo.  Buscaram-se  artigos  em  língua  inglesa  na  base  de  dados  Pubmed  com  termos
como Dexmedetomidine,  sevoﬂurane  (Methyl  Ethers/sevoﬂurane)  e  agitation  (Psychomotor
Agitation). Artigos  duplicados,  com  crianc¸as  que  receberam  medicac¸ão  pré-anestésica  e  que
usaram controle  ativo  foram  excluídos.  Adotou-se  modelo  de  efeitos  aleatórios  com  testes  de
DerSimonian-Laird  e  cálculo  de  odds  ratio  (OR)  para  variáveis  dicotômicas  e  diferenc¸a de  média
padronizada  para  variáveis  contínuas,  com  seus  respectivos  intervalos  de  conﬁanc¸a  de  95%  (IC).
Resultados:  Dos  146  estudos  identiﬁcados,  10  foram  selecionados,  com  558  pacientes  (282  no
grupo dex  e  276  controles).  O  uso  da  dex  foi  considerado  fator  de  protec¸ão  para  agitac¸ão  psi-
comotora  (OR  =  0,17;  95%  IC  0,13-0,23;  p  <  0,0001)  e  para  náuseas  e  vômitos  na  SRPA  (OR  =  0,49;
95% IC  0,35-0,68;  p  <  0,0001).  Tempo  para  despertar  e  para  alta  da  SRPA  foram  maiores  no  grupo
dexmedetomidina.  Não  houve  diferenc¸a entre  os  grupos  para  tempo  de  extubac¸ão  e  durac¸ão
da anestesia.
Conclusão:  A  dexmedetomidina  reduz  a  agitac¸ão  psicomotora  no  despertar  de  crianc¸as  sub-
metidas  à  anestesia  geral  com  sevoﬂurano.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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evoﬂurane  is  widely  used  in  pediatric  anesthesia  for  its
harmacological  proﬁle,  which  allows  rapid  inhalational
nduction  and  awakening  from  anesthesia,  low  hepatotox-
city  and  hemodynamic  stability.1 However,  the  occurrence
f  agitation  is  a  common  phenomenon  in  children  undergoing
eneral  anesthesia  with  sevoﬂurane.1
Emergence  agitation  in  children  was  ﬁrst  described  in
he  early  1960s  and  is  characterized  by  a  dissociated
tate  of  consciousness  in  which  the  child  becomes  incon-
olable,  irritable,  uncooperative,  and  sometimes  aggressive.
lthough  temporary,  it  is  an  extremely  distressing  event  for
hildren,  parents,  and  health  professionals.2
Prevalence  of  agitation  varies  from  25%  to  80%  in
he  literature,  depending  on  the  deﬁnition  and  criteria
sed  by  the  authors.1,3 It  is  inﬂuenced  by  the  technique
nd  anesthetic  agents.4 Different  drugs  such  as  opioids,Please  cite  this  article  in  press  as:  Amorim  MA,  et  al.  Effect  of  de
with  sevoﬂurane:  a  meta-analysis.  Rev  Bras  Anestesiol.  2016.  h
etamine,  benzodiazepines,  and  2-agonists,2 have  been
sed  in  the  prevention  and  treatment  of  agitation,  but
ith  varying  success,  which  contributes  to  the  development
o
e
cf  studies  to  improve  perioperative  care  delivered  to
hildren.
Dexmedetomidine  (Dex),  dextrorotatory  enantiomer  of
edetomidine,  is  a  highly  selective  2-adrenergic,  with  an
2:1 receptor  ratio  of  1,600:1,  and  important  sedative  and
nalgesic  effects.5 Its  sedative  effect  occurs  through  inter-
ction  with  postsynaptic  2-receptors  in  the  locus  coeruleus,
educes  noradrenalin  release,  and  facilitates  the  action  of
nhibitory  neurons,  particularly  gamma-aminobutyric  acid
ystem.  The  analgesic  effect  is  promoted  by  the  action  of  2-
eceptors  on  dorsal  horn  and  supraspinal  cord  and  decreased
elease  of  substance  P.6
Dexmedetomidine  has  been  used  to  reduce  psychomotor
gitation,  although  the  actual  beneﬁts  and  implications  in
nesthetic  practice  are  still  uncertain.  Thus,  the  aim  of  this
eta-analysis  was  to  evaluate  the  effects  of  dexmedetomi-
ine  on  emergence  agitation  in  children  undergoing  general
nesthesia  with  sevoﬂurane,  including  the  incidence  of  post-xmedetomidine  in  children  undergoing  general  anesthesia
ttp://dx.doi.org/10.1016/j.bjane.2016.02.007
perative  nausea  and  vomiting  (PONV),  emergence  time,
xtubation  time,  duration  of  anesthesia,  and  time  of  dis-
harge  from  the  post-anesthesia  recovery  room  (PACU).
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This  meta-analysis  consists  of  10  randomized  controlled  tri-
als  published  between  2004  and  2014,  which  assessed  the
effect  of  dexmedetomidine  on  emergence  agitation  in  chil-
dren  undergoing  general  anesthesia  with  sevoﬂurane.
Search result
(n=146)
Excluded duplicates
(n=20)
Title and abstract
reading (n=126)
Excluded: not relevant
(n=104), adults (n=6) and
active control (n=1)
Eligible for full-text
reading (n=15)
Studies included in the
meta-analysis (n=10)
Excluded for using
premedication (n=5)ARTICLEBJANE-757; No. of Pages 6
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Methods
This  is  a  meta-analysis  of  clinical  trials  evaluating  the
use  of  dexmedetomidine  to  prevent  emergence  agi-
tation  in  children  undergoing  general  anesthesia  with
sevoﬂurane.  PRISMA  guidelines7 were  followed  to  per-
form  a  systematic  review  and  meta-analysis  of  random-
ized  controlled  trials.  Articles  in  English  (2000--2014)
were  selected  in  the  Pubmed  database  with  key-
words  such  as  Dexmedetomidine,  sevoﬂurane  (Methyl
Ethers/sevoﬂurante)  and  agitation  (Psychomotor  Agitation),
or  its  synonyms  separated  by  AND/OR  interlocutors  with
the  following  search  strategy:  (dexmedetomidine[MeSH
Terms])  OR  adrenergic  alpha  agonists[MeSH  Terms])
OR  dexmedetomidine[Title/Abstract])  OR  dexmedetomi-
dine)  OR  adrenergic  alpha  agonists)  AND  anesthet-
ics,  intravenous[MeSH  Terms])  OR  anesthetics,  intra-
venous[Title/Abstract])  AND  (hypnotics  and  sedatives[MeSH
Terms]))  OR  (hypnotics  and  sedatives[Title/Abstract]))
AND  sevoﬂurane)  OR  sevoﬂurane[Title/Abstract])  OR
sevoﬂurane[Supplementary  Concept]))  AND  children[MeSH
Terms]))  AND  agitation,  psychomotor[MeSH  Terms].  In  addi-
tion  to  the  search,  we  reviewed  manually  the  references  of
studies  meeting  the  inclusion  criteria,  in  order  to  identify
original  studies  that  were  not  previously  found.
Randomized,  double-blind,  controlled  studies,  with
children  (under  10  years  old)  undergoing  elective  proce-
dures  under  general  anesthesia  with  sevoﬂurane,  using
dexmedetomidine  or  placebo  were  included.  Duplicate  arti-
cles  or  with  children  using  premedication,  involving  only
sedation  and  using  active  control  were  excluded.
Two  independent  researchers  (MA  and  CG)  conducted
a  preliminary  assessment  of  the  titles/abstracts  and  data
extraction.  Selected  studies  were  read  in  full  considering
the  inclusion  and  exclusion  criteria.  In  case  of  disagree-
ment,  a  third  researcher  (LC)  made  the  ﬁnal  evaluation.
Data  regarding  patient’s  age,  anesthesia  (Dex  dose),  type
of  procedure,  and  outcomes  were  recorded  on  a  standard-
ized  form  developed  by  the  authors.  For  this  study,  the
following  outcomes  were  considered:  emergence  agitation
(deﬁned  by  each  paper  according  to  the  scale  used:  Pae-
diatric  Anaesthesia  Emergence  Delirium  --  PAED,8 Watcha,9
and  ﬁve-point  scale)10;  PONV  (present  or  absent);  and
times  for  extubation,  emergence,  PACU  discharge,  and  dura-
tion  of  anesthesia  (time  interval  described  by  articles  in
minutes).
Sensitivity  analysis  was  planned  to  explore  sources  of
heterogeneity  between  studies,  when  present.  Statistical
heterogeneity  was  calculated  using  the  chi-square  method
(2)  and  Higgins’  test  (I2).11 Presence  of  heterogeneity
was  considered  at  p  <  0.05  and  I2 ≥  50%.  Odds  ratio  (OR)
with  95%  conﬁdence  interval  (CI)  was  used  to  quantify
the  statistical  difference  between  groups  for  dichotomous
variables  and  standardized  mean  difference  (SMD)  for  con-
tinuous  variables  (time  in  minutes).  After  assessing  the
quality  and  statistical  heterogeneity  of  studies,  we  adopted
the  random  effects  model  using  the  DerSimonian--Laird12
method  and  statistical  analysis  using  the  BioEstat
®
5.0
software.13 The  assessment  of  potential  for  publication  bias
was  made  by  visual  analysis  of  funnel  plots  and  Begg’s14Please  cite  this  article  in  press  as:  Amorim  MA,  et  al.  Effect  of  de
with  sevoﬂurane:  a  meta-analysis.  Rev  Bras  Anestesiol.  2016.  h
and  Egger’s15 tests,  with  statistical  signiﬁcance  level  set
at  5%. PRESS
hesia  with  sevoﬂurane  3
esults
nitially,  146  studies  were  identiﬁed  (116  studies  in  Pubmed
nd  30  manually  searched),  of  which  10  were  selected  to
ompose  this  meta-analysis,  as  shown  in  Fig.  1.
The  10  studies  included  558  patients,  282  in  the  inter-
ention  group,  and  276  in  the  control  group  (Table  1).
hree  studies  were  conducted  in  Turkey,17--19 three  studies
n  China,21--23 and  others  studies  in  Chile,1 United  States,16
apan,20 and  South  Korea.24
Emergence  agitation  was  assessed  in  10  studies,  and  the
se  of  dexmedetomidine  was  considered  a  protection  fac-
or  (OR  =  0.17;  95%  CI  0.13--0.23;  p  <  0.0001),  as  shown  in
ig.  2. Surgery  subgroup  analysis  showed  no  effect  change
urogenital1,24 with  OR  =  0.14;  95%  0.04--0.44;  p  =  0.0008;
phthalmic21,23 with  OR  =  0.06;  95%  CI  0.01--0.45;  p  =  0.0067,
NT,17,19 with  OR  =  0.20;  95%  CI  0.14--0.30;  p  <  0.0001).
The  use  of  dexmedetomidine  reduces  the  incidence
f  PONV  (Fig.  3),  with  OR  =  0.49  (95%  CI  0.35--0.68  and
 <  0.0001).
Emergence  time  was  assessed  in  seven  studies,17--19,21--23
SMD  =  1.78;  95%  CI  1.12--2.44;  p  =  0.0001)  and  PACU  dis-
harge  in  four  studies1,16,18,23 (SMD  =  8.54;  95%  CI  6.62--10.44;
 <  0.0001),  higher  in  dexmedetomidine  group.
There  was  no  difference  between  groups  regarding  extu-
ation  time  (SMD  =  0.70;  95%  CI  0.33--1.06;  p  =  0.0002),
ssessed  in  eight  studies,1,16--19,21--23 and  duration  of  anes-
hesia  (SMD  =  3.19;  95%  CI  −0.79--7.14;  p  =  0.11),  assessed  in
even  studies.1,16,18--20,23,24
Based  on  the  funnel  plot  analysis  (Fig.  4),  there  is  an
symmetry  with  no  small  sample  studies  to  the  right  of
he  summary  effect,  which  supports  a  potential  for  publica-
ion  bias  conﬁrmed  by  Begg’s  (p  =  0.02)  and  Egger’s  (p  =  0.03)
ests.
iscussionxmedetomidine  in  children  undergoing  general  anesthesia
ttp://dx.doi.org/10.1016/j.bjane.2016.02.007
Figure  1  Diagram  of  study  selection.
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Table  1  Description  of  selected  studies.
Study  Year  of  publication  Study  details  n  Age  Procedure  type
Ibacache1 2004 Dex  0.3  mcg  kg−1 30 1--10 Inguinal  hernia  repair,  orchidopexy
and  circumcisionSaline  solution  30
Shukry16 2005 Dex  0.2  mcg  kg−1 23 1--10 Elective  surgeries
Saline  solution 23
Guler17 2005 Dex  0.5  mcg  kg−1 30 3--7 Adenotonsillectomy
Saline  solution  30
Isik18 2006 Dex  1  mcg  kg−1 21 1--10 Magnetic  resonance  imaging
Saline solution  21
Erdil19 2009 Dex  0.5  mcg  kg−1 30 2--7 Adenoidectomy  with  or  without
myringotomySaline solution  30
Sato20 2010 Dex  0.3  mcg  kg−1 39 1--9 Outpatient  surgery
Saline solution  42
Lili21 2012 Dex  0.5  mcg  kg−1 30 3--7  Vitrectomy
Saline  solution  30
He22 2013 Dex  1  mcg  kg−1 32 3--7 Small  superﬁcial  surgeries
Saline solution  26
Chen23 2013 Dex  1  mcg  kg−1 27 2--7 Strabismus
Saline  solution  24
Kim24 2014 Dex  1  mcg  kg−1 20 1--5 Hernioplasty  or  orchidopexy
Saline solution  20
Weight (%)Control
(n/N)
9.3911/30
11.21
12.27
4.82
12.32
19.39
9.54
0.22 (0.06-0.82)
0.24 (0.07-0.82)
0.17 (0.05-0.53)
0.08 (0.01-0.51)
0.24 (0.08-0.78)
0.16 (0.04-0.62)
7.40
8.87
4.75
100
14/23
17/30
10/21
14/30
27/42
13/30
11/26
11/24
11/20
0.01 0.1 0.2 0.5 1.0 2.0 5.0 10.0
139/276
Dex
(n/N)
3/30
6/23
5/30
1/21
5/30
7/39
3/30
2/32
3/27
1/20
38/282
Favors
dexmedetomidine
Favors
control
Overall effect test:
Z=11.92 (p<0 .0001)
Study
Ibacache 2004
Shukry 2005
Guler 2005
Isik 2006
Erdil 2009
Sato 2010
Lili 2012
He 2013
Chen 2013
Kim 2014
Total
Heterogeneity test;
χ2 = 3.19; df=9 (p=0.96); I2 = 0% 
0.11 (0.02-0.49)
0.17 (0.04-0.66)
0.06 (0.01-0.41)
0.17 (0.13-0.23)
0.23 (0.09-0.57)
OR (95% CI)
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ligure  2  Meta-analysis  of  dexmedetomidine  effect  on  eme
evoﬂurane.
There  was  variation  in  dexmedetomidine  dosage
0.2--1.0  mcg  kg−1),  as  well  as  in  administration  technique.
ne  used  continuous  infusion  of  dexmedetomidine16 and
he  others  used  it  for  a  short  period,  ranging  from  5  to
0  min.  Regarding  the  time  of  administration,  only  one
tudy  administered  the  drug  at  the  end  of  the  procedure17
nd  all  others  after  induction  of  anesthesia,  with  similar
esults  regarding  emergence  agitation,  which  conﬁrms  that
here  is  no  ideal  time  for  dexmedetomidine  administration.
The  causes  of  emergence  agitation  following  generalPlease  cite  this  article  in  press  as:  Amorim  MA,  et  al.  Effect  of  de
with  sevoﬂurane:  a  meta-analysis.  Rev  Bras  Anestesiol.  2016.  h
nesthesia  are  multifactorial;  it  may  involve  pain,  anxiety,
nd  disorientation  on  rapid  awakening.25 In  an  attempt  to
inimize  this  event,  numerous  drugs  have  been  used,  such
s  opioids,  ketamine,  benzodiazepines,  and  2-agonists,
o
a
f
rce  agitation  in  children  undergoing  general  anesthesia  with
ut  with  uncertain  results.2 This  meta-analysis  presents
exmedetomidine  as  a  protective  factor  for  emergence
gitation  in  children  undergoing  general  anesthesia  with
evoﬂurane,  similar  result  already  described  by  other
uthors.2 Although  the  actual  mechanism  for  this  effect
emains  unknown,  it  is  believed  that  the  analgesic  and
edative  effects  of  dexmedetomidine  contribute  to  this
henomenon,  as  postoperative  analgesic  consumption  was
ower.2
Sevoﬂurane  has  been  associated  with  high  incidencexmedetomidine  in  children  undergoing  general  anesthesia
ttp://dx.doi.org/10.1016/j.bjane.2016.02.007
f  emergence  agitation  in  children  undergoing  general
nesthesia,1,17 even  without  surgery.18 This  fact  is  not  yet
ully  understood.  It  has  been  hypothesized  that  sevoﬂu-
ane  can  exert  an  irritating  effect  on  the  central  nervous
ARTICLE IN PRESS+ModelBJANE-757; No. of Pages 6
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Figure  3  Meta-analysis  of  dexmedetomidine  effect  on  nausea  and
with sevoﬂurane.
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system.26 The  decrease  in  emergence  agitation  provided  by
dexmedetomidine  may  also  be  justiﬁed  by  the  lower  con-
sumption  of  sevoﬂurane.27
PONV  are  common  complications  in  children  undergo-
ing  general  anesthesia  with  sevoﬂurane.18 Studies  have
shown  conﬂicting  results  on  the  effect  of  dexmedetomi-
dine  for  this  complication.20,23 In  the  present  study,  the
use  of  dexmedetomidine  appeared  as  a  protective  fac-
tor  for  the  incidence  of  nausea  and  vomiting.  The  use  of
dexmedetomidine  has  been  associated  with  reduced  need
for  postoperative  opioid  analgesics,  which  implies  a  lower
incidence  of  nausea  and  vomiting  induced  by  opioid.28 More-
over,  dexmedetomidine  has  been  used  successfully  in  the
treatment  of  cyclical  vomiting  syndrome  in  children,  by  yet-
unknown  mechanisms.29
In  this  study,  the  times  of  emergence  and  PACU  discharge
were  considered  statistically  higher  in  dexmedetomidine
group,  justiﬁed  by  its  sedative  effect,5 but  without  clinical
repercussions.17--19,22
Regarding  the  time  of  extubation  and  duration  of  anes-
thesia,  this  meta-analysis  found  no  statistically  signiﬁcant
difference  between  dexmedetomidine  and  control  groups.
This  result  disagrees  with  some  individual  studies,  by  ﬁnd-
ing  a  longer  extubation  time  and  duration  of  anesthesia  in
dexmedetomidine  group.17,18
It  is  noteworthy  that  the  studies  used  different  scales
to  assess  agitation.  One  study23 used  the  PAED  scale8,Please  cite  this  article  in  press  as:  Amorim  MA,  et  al.  Effect  of  de
with  sevoﬂurane:  a  meta-analysis.  Rev  Bras  Anestesiol.  2016.  h
four  studies1,16,21,24 used  the  Watcha  scale,9 and  ﬁve
studies17--20,22 used  the  ﬁve-point  scale.10 Although  only  the
PAED  scale  has  been  validated,8 the  others  are  widely  used
in  clinical  researches. vomiting  incidence  in  children  undergoing  general  anesthesia
The  meta-analysis  quality  depends  on  the  selection  of  rel-
vant  studies,  heterogeneity,  and  detection  bias.2 Despite
he  different  strategies  used  in  this  study  to  minimize  possi-
le  biases,  it  may  not  be  discarded.  A  search  was  conducted
n  an  important  database  and  selected  works  were  submitted
o  two  independent  evaluators.  Double-blind  randomized
linical  trials  were  included.  The  use  of  random  effects
odel  is  justiﬁed  by  the  observation  of  clinical  hetero-
eneity  identiﬁed  in  studies:  different  doses  and  times  of
exmedetomidine  administration,  procedures,  and  emer-
ence  assessment  scales.  Another  limitation  of  this  study
efers  to  the  use  of  only  one  database  for  search,  which
onﬁrms  the  occurrence  of  publication  bias,  as  identiﬁed  in
his  meta-analysis.
Due  to  its  good  hemodynamic  stability,  dexmedetomidine
as  been  used  as  an  adjuvant  anesthetic  and  may  be  used
s  pre-anesthetic  medication,  during  anesthesia,  or  even
ostoperatively,  and  provides  sedation  and  analgesia5 with-
ut  respiratory  depression.17,18,20,30 Its  use  entails  beneﬁts,
uch  as  lower  consumption  of  inhalational  anesthetics,21 less
eed  for  postoperative  analgesic  and  opioid  drugs,2,28 and
ower  oxygen  consumption.31
In  conclusion,  this  meta-analysis  highlights  the  use  of
exmedetomidine  in  reducing  emergence  agitation  in  chil-
ren  undergoing  general  anesthesia  with  sevoﬂurane.
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